Jonas Martzloff - Publications

Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.

Journal: Transplantation

Published: June 21, 2023

A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.

Journal: Kidney international

Published: June 21, 2022

High Incidence of Acute Kidney Injury in Patients Treated with High-Dose Amoxicillin and Cloxacillin Combination Therapy.

Journal: Antibiotics (Basel, Switzerland)

Published: May 06, 2022

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.

Journal: Journal of personalized medicine

Published: May 05, 2022

Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 25, 2022

Adequacy between practice and European guidelines on hyponatremia: a survey among French nephrologists.

Journal: Clinical kidney journal

Published: March 23, 2022

French nationwide survey of undocumented end-stage renal disease migrant patient access to scheduled haemodialysis and kidney transplantation.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 18, 2021

Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 26, 2021

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.

Journal: Kidney international

Published: April 09, 2021

SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.

Journal: Transplantation

Published: March 23, 2021

Diabetic kidney disease versus non-diabetic kidney disease in type 2 diabetic patients on dialysis: An observational cohort.

Journal: Endocrinology, diabetes & metabolism

Published: March 23, 2021

Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.

Journal: Kidney international

Published: March 02, 2021